focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksROL.L Regulatory News (ROL)

  • There is currently no data for ROL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

17 Mar 2022 09:15

RNS Number : 1218F
Rotala PLC
17 March 2022
 

 

RNS

 

17 March 2022

 

 

Rotala Plc

("Rotala", the "Company" or the "Group")

 

Directors' dealings: Grant of Share Options

 

The Company announces that, on 16 March 2022, it granted options over a total of 3,200,000 ordinary shares of 25p each ("Ordinary Shares") in the capital of the Company (the "New Options"), all of which have an exercise price of 25.0 pence per share, to each of the Company's executive directors, Simon Dunn, Robert Dunn and Kim Taylor. The Board's Remuneration Committee decided to take this step in order to incentivise management as the Group recovers from COVID-19. Further details of the terms of the New Options are set out below.

 

Background

 

The Company has not made any awards to executive directors under the Rotala plc 2005 Share Option Scheme (the "Scheme"), except for grants of SAYE options, since 2014. The Scheme was established in 2005, when the Company was first admitted to trading on AIM, and was intended to encompass the issue of share options to the Board and senior management, as well as SAYE option grants to all levels of employees. The Scheme permits the issue of share options up to 13.47% of the total number of the Company's shares in issue (including, for these purposes, shares held in Treasury by the Company). The Company's current issued share capital is 50,924,918 Ordinary Shares, of which 800,000 are held in Treasury.

 

Prior to the grant of the New Options, the following share options were in issue:

 

Date of grant

Number of options granted

Earliest exercise date

Date of expiry

Exercise price

24 November 2014

1,910,000

24 November 2017

23 November 2024

54.0p

15 October 2021

800,000

15 October 2021

23 November 2024

29.0p

 

In respect of the issue of 24 November 2014, the share options are split into three equal tranches. For a tranche to be exercisable, the market price of the Ordinary Shares must have reached 65.0p, 80.0p and 95.0p respectively. At the date of this announcement, the market price vesting condition has been met only in respect of the first tranche.

 

In respect of the issue of 15 October 2021, for the share options to be exercisable, the market price of the Ordinary Shares must have reached 75.0p. At the date of this announcement, the market price vesting condition has not been met.

 

Each of Simon Dunn, Robert Dunn and Kim Taylor have been granted 2,000,000, 800,000 and 400,000 New Options respectively. For the New Options to be exercisable, the market price of the Ordinary Shares must have been sustained at prices between 56.0p and 62.0p per share over a period of at least 20 consecutive business days.

 

Options outstanding

 

Following the issue of the New Options, the following share options are now in issue:

 

Date of grant

Number of options granted

Earliest exercise date

Date of expiry

Exercise price

24 November 2014

1,910,000

24 November 2017

23 November 2024

54.0p

15 October 2021

800,000

15 October 2021

23 November 2024

29.0p

16 March 2022

3,200,000

16 March 2022

23 November 2024

25.0p

 

This amounts to a total of 5,910,000 share options, being 11.61% of the total number of the Company's shares in issue (including those held in Treasury). The Remuneration Committee decided to set the expiry date of the New Options to be the same as the existing share options so that the matter of share option awards could be considered afresh in November 2024.

 

After the grant of the New Options, the Company's executive directors hold the following options over Ordinary Shares:

 

Number of options granted

Earliest date exercisable

Date of expiry

Exercise price

Market price vesting condition

S Dunn

577,778

16/03/2022

23/11/2024

25.0p

56.0p

663,704

16/03/2022

23/11/2024

25.0p

60.0p

758,518

16/03/2022

23/11/2024

25.0p

62.0p

300,000

24/11/2017

23/11/2024

54.0p

65.0p

300,000

24/11/2017

23/11/2024

54.0p

80.0p

300,000

24/11/2017

23/11/2024

54.0p

95.0p

2,900,000

R Dunn

231,111

16/03/2022

23/11/2024

25.0p

56.0p

265,481

16/03/2022

23/11/2024

25.0p

60.0p

303,408

16/03/2022

23/11/2024

25.0p

62.0p

205,000

24/11/2017

23/11/2024

54.0p

65.0p

205,000

24/11/2017

23/11/2024

54.0p

80.0p

205,000

24/11/2017

23/11/2024

54.0p

95.0p

1,415,000

K Taylor

115,556

16/03/2022

23/11/2024

25.0p

56.0p

132,741

16/03/2022

23/11/2024

25.0p

60.0p

151,703

16/03/2022

23/11/2024

25.0p

62.0p

131,666

24/11/2017

23/11/2024

54.0p

65.0p

131,667

24/11/2017

23/11/2024

54.0p

80.0p

131,667

24/11/2017

23/11/2024

54.0p

95.0p

795,000

 

The remaining 800,000 share options in issue are held by senior management who are not members of the Board of Rotala.

 

 

Rotala Plc

0121 322 2222

Graham Spooner, Deputy Chairman and Chairman of the Remuneration CommitteeSimon Dunn, Chief ExecutiveKim Taylor, Group Finance Director

 

Shore Capital

 

020 7408 4090

Tom Griffiths / James Thomas / Michael McGloin (Corporate Advisory)Henry Willcocks (Corporate Broking)

About the business 

Rotala provides a range of transport solutions, ranging from local bus services under contract to local authorities, through to commercial bus routes. Rotala has operations at Heathrow Airport, in the West Midlands and in the North West. Operating companies are Diamond Bus Ltd, Diamond Bus (North West) Ltd, Hallmark Connections Ltd and Preston Bus Ltd.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKOBDCBKKNND
Date   Source Headline
18th Mar 20229:26 amRNSDirector/PDMR Shareholding
17th Mar 20229:15 amRNSGrant of Share Options
17th Mar 20229:15 amRNSDirector/PDMR Shareholding
16th Mar 202210:58 amRNSDirector/PDMR Shareholding
15th Mar 20227:01 amRNSNew Banking Facilities
15th Mar 20227:00 amRNSFinal results for the year ended 30 November 2021
9th Mar 20223:12 pmRNSOutcome of Judicial Review Hearing
22nd Dec 20213:29 pmRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSTrading Update
13th Dec 202111:51 amRNSDirector/PDMR Shareholding
13th Dec 202111:47 amRNSDirector/PDMR Shareholding
10th Dec 20211:01 pmRNSDirector/PDMR Shareholding
1st Dec 20214:38 pmRNSDirector/PDMR Shareholding
30th Nov 20212:24 pmRNSDirector/PDMR Shareholding
25th Nov 20219:43 amRNSDirector/PDMR Shareholding
22nd Nov 202112:15 pmRNSDirector/PDMR Shareholding
19th Nov 202112:49 pmRNSDirector/PDMR Shareholding
17th Nov 20212:32 pmRNSDirector/PDMR Shareholding
23rd Sep 202112:43 pmRNSHolding(s) in Company
25th Aug 20211:59 pmRNSDirector/PDMR Shareholding
25th Aug 20211:49 pmRNSDirector/PDMR Shareholding
20th Aug 20213:34 pmRNSDirector/PDMR Shareholding
27th Jul 202110:33 amRNSDirector/PDMR Shareholding
20th Jul 20217:00 amRNSInterim Results for 6 months to 31 May 2021
1st Jun 20217:00 amRNSResult of AGM
28th May 20218:23 amRNSAGM Statement
17th May 20217:00 amRNSBus Service Improvement Plans
11th May 20217:00 amRNSDirector/PDMR Shareholding
7th May 20217:00 amRNSDirector/PDMR Shareholding
7th May 20217:00 amRNSDirector/PDMR Shareholding
7th May 20217:00 amRNSAnnual Report & AGM
6th May 20217:00 amRNSFinal results for the year ended 30 November 2020
26th Mar 20217:00 amRNSGreater Manchester Bus Reform Decision
19th Feb 20218:00 amRNSFire at Heathrow Depot
21st Jan 202112:50 pmRNSDirector/PDMR Dealing
11th Jan 20217:00 amRNSTrading Update
16th Nov 20207:00 amRNSUpdate
26th Oct 20207:00 amRNSChange of Adviser
20th Oct 20201:37 pmRNSDirector/PDMR Shareholding
6th Oct 20202:04 pmRNSDirector/PDMR Shareholding
30th Sep 202011:28 amRNSDirector/PDMR Shareholding
29th Sep 202011:42 amRNSDirector/PDMR Shareholding
25th Sep 20203:15 pmRNSDirector/PDMR Shareholding
18th Sep 20203:54 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSHalf-year Report
19th Aug 20202:54 pmRNSNotice of Interim Results
22nd Jul 20201:00 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSResult of AGM
26th May 202011:11 amRNSSale of Long Leasehold Depot

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.